May 5, 2010 — The US Food and Drug Administration (FDA) has approved a fixed-dose tablet combination of delayed-release enteric-coated naproxen and immediate-release esomeprazole magnesium (Vimovo; ...
(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced Thursday the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. market. The tablets are a ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Phase III trials showed that therapy reduces risk of gastric ulcers in inflammatory disease patients. Pozen received a $20 million milestone payment from AstraZeneca upon FDA approval of the companies ...
Thirty-two healthy subjects (13 males and 19 females) with a mean age of 24 years and a mean bodyweight of 69kg participated in the eso- meprazole and naproxen study (study A). Thirty-one subjects ...
DUBLIN, Ireland, June 27, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and ...
Irish drug company Horizon Pharma has hiked the price of a two-in-one painkiller by more than 2,000 percent in the past five years, according to a report in Financial Times A 60-pill bottle of the ...
(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced Thursday the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. market. The tablets are a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback